Azenta Inc at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum (Virtual) Transcript
Good afternoon. This is Paul Knight at KeyBanc. I'm the analyst on Azenta. I'd like to welcome Sara Silverman, Investor Relations; and Lindon Robertson, who's Chief Financial Officer. I think what the format is an overview, and then we'll open it up for questions. You can use it on the screen dialogue in front of you to ask questions or you can e-mail them to myself at [email protected].
With that, Lindon, I'll let you start with the presentation.
Excellent. Thanks, Paul, and thanks for inviting us, including us on your format here. We'll get right into it. Obviously, with the presentation, we always put the safe harbor upfront, and we won't be obligated to make updated statements. And we will use non-GAAP measures, which we would encourage everyone to use in context of GAAP measures as well.
So as a company, we crossed over $0.5 billion in revenue last year. And we were separated out
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |